mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.6 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |